Bioventix Plc - Holding(s) in Company

PR Newswire

London, January 13


For filings with the FCA include the annex
For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii		Bioventix (Sedol B4QVDF0)
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights			X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii	CASTLEFIELD FUND PARTNERS LIMITED
4. Full name of shareholder(s) (if different from 3.):iv
5. Date of the transaction and date on which the threshold is crossed or reached: v	9th January 2017
6. Date on which issuer notified:	12th January 2017
7. Threshold(s) that is/are crossed or reached: vi, vii	5%


8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction						Resulting situation after the triggering transaction
Number of Shares			Number of Voting Rights			Number of shares		Number of voting rights			% of voting rights x
Direct		Direct xi		Indirect xii	Direct			Indirect
GB00B4QVDF07	250,000			250,000			265,000		265,000			5.197%

B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument			Expiration date xiii		Exercise/ Conversion Period xiv					Number of voting rights that may be acquired if the instrument is exercised/ converted.				% of voting rights


C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial instrument		Exercise price		Expiration date xvii		Exercise/ Conversion period xviii			Number of voting rights instrument refers to				% of voting rights xix, xx
													Nominal		Delta


Total (A+B+C)
Number of voting rights								Percentage of voting rights
265,000								5.197%


9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi


Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:	Percentage based on Issued Share Capital of 5,098,656
14. Contact name:	Richard Vickers
15. Contact telephone number:	0161 233 4890


Note: Annex should only be submitted to the FSA not the issuer
Annex: Notification of major interests in sharesxxii

A: Identity of the persons or legal entity subject to the notification obligation
Full name (including legal form of legal entities)
Contact address (registered office for legal entities)
Phone number & email
Other useful information (at least legal representative for legal persons)

B: Identity of the notifier, if applicable
Full name
Contact address
Phone number & email
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)

C: Additional information

*For notes on how to complete form TR-1 please see the FSA website.*

AI Terminal